About

Technologies

Support

Contact

About

Technologies

Support

Contact

About

Technologies

Support

Contact

FABI Foundation: Fighting Against Brain Injury

Welcome to the FABI Foundation. We are a not-for-profit organization dedicated to advancing clinical research and treatment development for traumatic brain injury (TBI). We focus on overlooked treatment options, and aim to improve the lives of those affected, including athletes in contact sports.

friendly female pediatrician touches shoulder teenage

Mission Statement

The FABI Foundation is dedicated to advancing the diagnosis and treatment of Traumatic Brain Injury (TBI) through innovative research and clinical trials. Our mission is to transform the landscape of TBI care, enhance the lives of those affected, and empower communities through education and awareness. Together, we commit to fighting against brain injury and creating a future where effective solutions are accessible to all.

Rapid Proof of Concept

Bring repurposing candidates to clinical proof of concept.

Cost-Effective Management of clinical programs

Manage clinical programs at low costs.

Funding Collaboration

Fund qualified programs in both academic and commercial settings with partners committed to rapid development.

How FABI works

Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.

Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.

Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.

Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.
Strategic Partnerships:

Collaborations with commercial manufacturers are planned after clinical proof of concept is achieved.
Guided by Expert Oversight:

Our Scientific Advisory Board ensures projects are selected based on scientific promise and potential impact.
Not-for-Profit Mission:

We pursue high-risk, high-reward projects that for-profit entities often avoid.

Our Approach

FABI seeks to close the treatment gap by repurposing therapies with established safety profiles. By advancing technologies we can improve treatment efficacy. Through the funding of clinical trials and innovative assessment methodologies, FABI works to accelerate the development of effective treatments for patients with brain injuries.

Get in touch

The Need for TBI Treatment

Despite the high incidence of TBIs from sports, falls, and accidents, current treatment options are limited. Promising therapies are underfunded and undeveloped. FABI Foundation steps in to fill this gap, repurposing safe existing compounds and using new methodologies to bring effective treatment options to those in need.

Traumatic Brain Injury (TBI) & Chronic Traumatic Encephalopathy (CTE): Key Facts - North America

Traumatic Brain Injury in Canada

Traumatic Brain Injury in the United States

Chronic Traumatic Encephalopathy (CTE) & Spofts-Related Brain Injury

Why These Numbers Matter

Scientific Advisory Board

Robert Bender

Chairman, Advisory Board

Robert Bender is an accomplished leader with over 40 years of experience in

life sciences and healthcare, specializing in commercializing innovative

technologies. He has co-founded and served in executive roles at several

companies, including Bio Logicals, and Neurochem. As the founder and Chair

of Revivo Therapeutics, he focuses on clinical-stage assets for CNS

indications, and as Chair and CEO of Banting Corp., he is developing a new

class of nutritional supplements.

companies, including Bio Logicals, and Neurochem. As the founder and Chair of Revivo Therapeutics, he focuses on clinical-stage assets for CNS indications, and as Chair and CEO of Banting Corp., he is developing a new class of nutritional supplements.

Robert Bender is an accomplished leader with over 40 years of experience in life sciences and healthcare, specializing in commercializing innovative technologies. He has co-founded and served in executive roles at several companies, including Bio Logicals, and Neurochem. As the founder and Chair of Revivo Therapeutics, he focuses on clinical-stage assets for CNS indications, and as Chair and CEO of Banting Corp., he is developing a new class of nutritional supplements.

Robert Bender is an accomplished leader with over 40 years of experience in life sciences and healthcare, specializing in commercializing innovative

technologies. He has co-founded and served in executive roles at several

companies, including Bio Logicals, and Neurochem. As the founder and Chair of Revivo Therapeutics, he focuses on clinical-stage assets for CNS

indications, and as Chair and CEO of Banting Corp., he is developing a new

class of nutritional supplements.

Dr. Donald Weaver
MD, PhD, FRCPC, FCAHS

Advisor

Dr. Donald Weaver, is a distinguished medical professional and clinical neurologist dedicated to advancing epilepsy research and treatment. A graduate of Queen’s University, he has extensive training in both medicine and organic chemistry, specializing in the development of novel therapies. Currently, he serves as Director and Senior Scientist at the Krembil Research Institute, and holds a professorship at the University of Toronto across multiple disciplines. Additionally, Dr. Weaver is the Chief Medical Officer of Treventis Corporation and a leading voice in the epilepsy community, having previously served as President of Epilepsy Canada.

Yakov Kogan
PhD, MBA

Advisor

Yakov Kogan is an accomplished biotechnology executive with over two decades of

experience in corporate strategy, financing, and drug development, guiding therapies

from early R&D through Phase III/BLA. He has led private and public biotech

companies, navigating complex regulatory landscapes, advancing preclinical and

clinical programs in oncology, radiation protection, and CNS-related indications, and

secured significant DoD and NIH grant support. With deep expertise in translational

research, regulatory strategy, and partnership building, Yakov brings a proven ability to

bridge science, clinical development, and funding - well aligned with the mission of the

FABI Foundation’s Scientific Advisory Board.

Yakov Kogan is an accomplished biotechnology executive with over two decades of experience in corporate strategy, financing, and drug development, guiding therapies

from early R&D through Phase III/BLA. He has led private and public biotech companies, navigating complex regulatory landscapes, advancing preclinical and

clinical programs in oncology, radiation protection, and CNS-related indications, and secured significant DoD and NIH grant support. With deep expertise in translational

research, regulatory strategy, and partnership building, Yakov brings a proven ability to bridge science, clinical development, and funding - well aligned with the mission of the FABI Foundation’s Scientific Advisory Board.

Yakov Kogan is an accomplished biotechnology executive with over two decades of experience in corporate strategy, financing, and drug development, guiding therapies

from early R&D through Phase III/BLA. He has led private and public biotech companies, navigating complex regulatory landscapes, advancing preclinical and clinical programs in oncology, radiation protection, and CNS-related indications, and secured significant DoD and NIH grant support. With deep expertise in translational research, regulatory strategy, and partnership building, Yakov brings a proven ability to bridge science, clinical development, and funding - well aligned with the mission of the

FABI Foundation’s Scientific Advisory Board.

Yakov Kogan is an accomplished biotechnology executive with over two decades of experience in corporate strategy, financing, and drug development, guiding therapies from early R&D through Phase III/BLA. He has led private and public biotech companies, navigating complex regulatory landscapes, advancing preclinical and clinical programs in oncology, radiation protection, and CNS-related indications, and

secured significant DoD and NIH grant support. With deep expertise in translational research, regulatory strategy, and partnership building, Yakov brings a proven ability to bridge science, clinical development, and funding - well aligned with the mission of the FABI Foundation’s Scientific Advisory Board.

Dr. Alexander A,Grunsfeld
M.D.

Advisor

Dr. Alexander A,Grunsfeld,M.D. is a highly respected neurologist and vascular neurology specialist, who is the medical director for Neurosciences at Sentara Healthcare based in Virginia. He earned his M.D. from Rutgers Medical School in 2002, followed by a residency in neurology and fellowship training in neurocritical care at the University of Virginia. With over two decades of clinical experience. Dr. Grunsfeld is board certified in both Neurology and Vascular Neurology. He is recognized for his work in stroke care leveraging advanced telemedicine and Al-driven imaging to improve rapid diagnosis and treatment outcomes.

Dr. Allan M. Green
M.D., PhD., J.D.

Advisor

Dr. Allan M. Green, is a distinguished physician, scientist, and legal expert with decades of experience at the intersection of medicine, biotechnology, and regulatory affairs. Board-certified in Internal Medicine and Nuclear Medicine, he has held senior leadership roles in major medical product companies and founded innovative ventures in neuro-imaging and life sciences. Dr. Green is widely recognized for his expertise in navigating complex FDA approval pathways, clinical trial development and translational research. His multidisciplinary background and strategic insight make him a valuable contributor to advancing research, policy, and innovation in the field of traumatic brain injury.

Board Of Directors

Dr. Sonja Jevric

Member of Board

Dr. Sonja Jevric is a duly and fully licensed Chiropractor with the College of Chiropractors of

Ontario and a member of the Canadian Chiropractic Association since 1997. She holds a

Bachelor’s Degree in Toxicology from the University of Toronto and a Masters’ degree in

Psychotherapy and Counselling from Yorkville University. She has over 28 years of experience

of clinical experience, assessing and treating patients including those suffering with traumatic

brain injuries. She is certified in AMA Catastrophic Impairment and has extensive experience as

a Case Manager in Ontario, with over 20 years of experience in this role, advocating for clients

with traumatic brain injuries.

Dr. Sonja Jevric is a duly and fully licensed Chiropractor with the College of Chiropractors of Ontario and a member of the Canadian Chiropractic Association since 1997. She holds a

Bachelor’s Degree in Toxicology from the University of Toronto and a Masters’ degree in Psychotherapy and Counselling from Yorkville University. She has over 28 years of experience

of clinical experience, assessing and treating patients including those suffering with traumatic brain injuries. She is certified in AMA Catastrophic Impairment and has extensive experience as

a Case Manager in Ontario, with over 20 years of experience in this role, advocating for clients with traumatic brain injuries.

Dr. Sonja Jevric is a duly and fully licensed Chiropractor with the College of Chiropractors of Ontario and a member of the Canadian Chiropractic Association since 1997. She holds a Bachelor’s Degree in Toxicology from the University of Toronto and a Masters’ degree in Psychotherapy and Counselling from Yorkville University. She has over 28 years of experience of clinical experience, assessing and treating patients including those suffering with traumatic brain injuries. She is certified in AMA Catastrophic Impairment and has extensive experience as a Case Manager in Ontario, with over 20 years of experience in this role, advocating for clients with traumatic brain injuries.

Magaly Bianchini

Member of Board

Magaly Bianchini is a seasoned business leader with a proven track record in real estate

development, construction, and renewable energy initiatives. As the former President of Leader

Capital Corp., she spearheaded key projects, including the successful development of land in

Ontario and Quebec and a 200 megawatt wind farm.Her longstanding role on the advisory board of a retirement home company showcases her commitment to community and sustainability, making her an exceptional candidate for the FABI Foundation Board of Directors.

Magaly Bianchini is a seasoned business leader with a proven track record in real estate development, construction, and renewable energy initiatives. As the former President of Leader

Capital Corp., she spearheaded key projects, including the successful development of land in Ontario and Quebec and a 200 megawatt wind farm.Her longstanding role on the advisory board of a retirement home company showcases her commitment to community and sustainability, making her an exceptional candidate for the FABI Foundation Board of Directors.

Magaly Bianchini is a seasoned business leader with a proven track record in real estate development, construction, and renewable energy initiatives. As the former President of Leader Capital Corp., she spearheaded key projects, including the successful development of land in Ontario and Quebec and a 200 megawatt wind farm.Her longstanding role on the advisory board of a retirement home company showcases her commitment to community and sustainability, making her an exceptional candidate for the FABI Foundation Board of Directors.

Magaly Bianchini is a seasoned business leader with a proven track record in real estate development, construction, and renewable energy initiatives. As the former President of Leader Capital Corp., she spearheaded key projects, including the successful development of land in Ontario and Quebec and a 200 megawatt wind farm. Her longstanding role on the advisory board of a retirement home company showcases her commitment to community and sustainability, making her an exceptional candidate for the FABI Foundation Board of Directors.

Management

Grace Casale

Grace Casale is the President of the FABI Foundation. She has a long history of leadership and community service, including time as President and Chair of the Etobicoke Distress Centres. With a strong background in fundraising and capital markets, Grace has also worked as a consultant in the medical sector, helping companies grow through sales, marketing, and strategic partnerships. Throughout her career, she has been passionate about connecting people and resources to create meaningful impact. Grace now brings this dedication and experience to the Foundation, where her focus is on advancing its mission and supporting the communities it serves.

Board Of Directors

Join Us

Join Us in the Fight Against Brain Injury
Whether you’re an athlete, a healthcare supporter, or someone passionate about advancing treatment for brain injuries, your involvement makes a difference. Help us accelerate the path to safer, effective treatments.

Get in touch

Support the FABI Foundation

At the FABI Foundation, we believe in the transformative power of generosity. Your contributions enable us to create lasting impact and foster positive change within our communities. We invite you to join our mission by considering a donation that reflects your commitment to a better tomorrow.

Elevate possibilities

Your gift of $2,500, $5,000 and $10,000, or more can help us drive essential initiatives, support innovative programs, and empower underserved populations. Together, we can unlock new opportunity, inspire hope, and champion the causes that matter most.

Join Our Exclusive Circle of Benefactors

When you choose to support the FABI Foundation, you become part of a group of visionaries, including corporate partners, professional athletes and individuals who have made substantial commitments to the treatment of brain injuries. Your contribution will support our current endeavours and play a pivotal role in shaping the future of treatments which address the major medical problem of TBI and its consequences.

smiling happily caregiver hugging her old

Ways to Donate

Corporate Partnerships

Align your organization with a mission that resonates with your values. Through tailored engagement opportunities, you can elevate your corporate social responsibility efforts while making a profound difference.

Individual Contributions

If you are an athlete, business leader, or individual who shares our vision, we invite you to make a personal commitment that reflects your dedication to the community.

Embark on a Journey of Discovery

To discuss options for your donation or to explore partnership opportunities, please contact us directly at grace@fabifoundation.com
Together, let us pave the way for enduring change and inspire others to join us on this remarkable journey.

Thank you for considering a transformative contribution to the FABI Foundation. Your support empowers us to envision a brighter future.

Get in touch

Submissions for Innovative Technologies and Clinical Trials in Brain Injury

We are seeking innovative solutions for brain injury treatment.

The FABI Foundation is dedicated to advancing the understanding and treatment of brain injuries through funding innovative technologies and supporting groundbreaking clinical trials. We invite researchers, organizations, and technology developers to present their proposals for projects that display the potential to make a significant impact in this critical area of health

brunette-female-doctor-talking-patient-doctors

Opportunity for funding

The Foundation is currently accepting proposals for technologies and clinical trials focused on brain injury rehabilitation, recovery, and related therapeutic and diagnostic interventions. We are interested in projects that aim to:

Develop innovative therapeutic technologies
Conduct clinical trials on new treatment methods
Enhance neuro-rehabilitation practices
Explore novel approaches to brain injury diagnostics

Submission Guidelines

To be considered for funding, please submit a single page summary that includes:

A brief overview of your technology or study (one or two paraghraphs)
A clear outline of the funding required and its planned use
Expected outcomes and timelines for your project
Clear contact information (email is sufficient)

By submitting you proposal to FABI you agree that FABI shall have no obligations with respect to any proposal ; we will inform you as to next steps appropriate.

Get in touch

Want to know more about the FABI Foundation? Send us a message and we will get back to you.

FABI Foundation: Fighting Against Brain Injury

Mission Statement

Mission Statement